Global Emergencies in Child Health: Challenges and Solutions—Viewpoint and Recommendations from the European Paediatric Association and the International Pediatric Association

Global emergencies, including natural disasters, epidemics, drought, armed conflicts, and the SARS-CoV-2 pandemic, have affected populations on five continents, causing devastating socioeconomic effects.Children are a most vulnerable and defenseless group. In tense situations, they feel overwhelmed and insecure and are often left to their own devices. Their rights to protection and integrity are threatened.3 The European Paediatric Association, Union of the National European Paediatrics Societies and Associations and the International Pediatric Association, representing the national pediatric societies from 149 countries, held a joint conference on October 9, 2021, in Zagreb, Croatia, to discuss the issue of global emergencies in pediatrics and their significant economic and social impact. Delegates discussed the challenges posed by a wide variety of emergencies in the context of increasing global complexities, while also exploring possible solutions. This article, prepared by the European Paediatric Association, Union of the National European Paediatrics societies and Associations–International Pediatric Association working group, includes the viewpoint and recommendations from the conference he group strongly recommends that countries develop, reorganize, and strengthen their health systems to address the social and environmental issues caused by global emergencies to enable more efficient and effective allocation and use of available resources for disaster preparedness and emergency response resources in communities. The statement emphasizes the importance of active involvement of all stakeholders, including governments and healthcare professionals. Their joint effort should focus on developing strategic partnerships with key international constituencies, such as the diplomatic, nongovernmental, legal, and academic communities, and the media with the aim of providing adequate support to infants, children, and adolescents affected by adversities.6 Pediatricians and their professional societies across the world must collaborate and share their experiences with new and emerging challenges in child health and together mitigate against inequalities within and between countries and between continents and together strongly and courageously advocate for the health and well-being of children

Serotype distribution of Streptococcus pneumoniae in children with invasive diseases in Turkey: 2008–2014

PubMed ID: 26325175Successful vaccination policies for protection from invasive pneumococcal diseases (IPD) dependent on determination of the exact serotype distribution in each country. We aimed to identify serotypes of pneumococcal strains causing IPD in children in Turkey and emphasize the change in the serotypes before and after vaccination with 7-valent pneumococcal conjugate vaccine (PCV-7) was included and PCV-13 was newly changed in Turkish National Immunization Program. Streptococcus pneumoniae strains were isolated at 22 different hospitals of Turkey, which provide healthcare services to approximately 65% of the Turkish population. Of the 335 diagnosed cases with S. pneumoniae over the whole period of 2008–2014, the most common vaccine serotypes were 19F (15.8%), 6B (5.9%), 14 (5.9%), and 3 (5.9%). During the first 5 y of age, which is the target population for vaccination, the potential serotype coverage ranged from 57.5 % to 36.8%, from 65.0% to 44.7%, and from 77.4% to 60.5% for PCV-7, PCV-10, and PCV-13 in 2008–2014, respectively. The ratio of non-vaccine serotypes was 27.2% in 2008–2010 whereas was 37.6% in 2011–2014 (p=0.045). S. penumoniae serotypes was less non-susceptible to penicillin as compared to our previous results (33.7 vs 16.5 %, p=0.001). The reduction of those serotype coverage in years may be attributed to increasing vaccinated children in Turkey and the increasing non-vaccine serotype may be explained by serotype replacement. Our ongoing IPD surveillance is a significant source of information for the decision-making processes on pneumococcal vaccination. © 2016 Taylor & Francis Group, LLC.PfizerThis study was supported by Pfizer. -